- Home
- SYBX vs CMBM Comparison
SYBX vs CMBM Comparison
Compare SYBX & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- CMBM
- Stock Information
- Founded
- SYBX N/A
- CMBM 2011
- Country
- SYBX United States
- CMBM United States
- Employees
- SYBX N/A
- CMBM N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- SYBX Health Care
- CMBM Technology
- Exchange
- SYBX Nasdaq
- CMBM Nasdaq
- Market Cap
- SYBX 16.4M
- CMBM 18.6M
- IPO Year
- SYBX N/A
- CMBM 2019
- Fundamental
- Price
- SYBX $1.71
- CMBM $0.71
- Analyst Decision
- SYBX
- CMBM Buy
- Analyst Count
- SYBX 0
- CMBM 1
- Target Price
- SYBX N/A
- CMBM $3.00
- AVG Volume (30 Days)
- SYBX 21.1K
- CMBM 179.7K
- Earning Date
- SYBX 11-11-2025
- CMBM 11-06-2025
- Dividend Yield
- SYBX N/A
- CMBM N/A
- EPS Growth
- SYBX N/A
- CMBM N/A
- EPS
- SYBX N/A
- CMBM N/A
- Revenue
- SYBX N/A
- CMBM $172,215,000.00
- Revenue This Year
- SYBX N/A
- CMBM N/A
- Revenue Next Year
- SYBX N/A
- CMBM $17.73
- P/E Ratio
- SYBX N/A
- CMBM N/A
- Revenue Growth
- SYBX N/A
- CMBM N/A
- 52 Week Low
- SYBX $0.90
- CMBM $0.23
- 52 Week High
- SYBX $1.96
- CMBM $2.08
- Technical
- Relative Strength Index (RSI)
- SYBX 69.98
- CMBM 48.64
- Support Level
- SYBX $1.45
- CMBM $0.62
- Resistance Level
- SYBX $1.77
- CMBM $0.78
- Average True Range (ATR)
- SYBX 0.07
- CMBM 0.05
- MACD
- SYBX 0.03
- CMBM 0.00
- Stochastic Oscillator
- SYBX 83.33
- CMBM 49.53
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.